Max Minute: Benefits Of Convalescent Plasma Therapy To COVID-19 Patients Unclear, Despite FDA’s Emergency Use Authorization

Max Minute: Benefits Of Convalescent Plasma Therapy To COVID-19 Patients Unclear, Despite FDA’s Emergency Use Authorization

CBS 2

Published

In a surprise move, the U.S. Food and Drug Administration reversed course over the weekend and gave emergency use authorization to an antibody treatment for COVID-19.

Full Article